A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including business acquisition news from Sun Pharma and Labcorp as well as new research from the National Sleep Foundation.
NEW YORK, March 14, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed.
The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download.
Continue Reading
PR Newswire Weekly Health Press Release Roundup, March 10-14, 2025.
Sun Pharma to Acquire Checkpoint Therapeutics
"We are excited to enter this transaction with Sun Pharma as the next step to bringing UNLOXCYT to cSCC [metastatic cutaneous squamous cell carcinoma] patients in need of a differentiated immunotherapy treatment option," said James Oliviero, President and Chief Executive Officer of Checkpoint.
Labcorp Announces Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses
Labcorp will acquire BioReference Health's laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States. The assets that Labcorp will be acquiring currently generate approximately $85 million to $100 million in annual revenue.
National Sleep Foundation Research Reveals Nearly 1/3 of Americans Diagnosed with Sleep Apnea are Not Receiving Treatment Despite Health Risks Findings revealed 78% of Americans aren't aware of all the treatment options available for sleep apnea and only 1 in 4 Americans can identify the health consequences of untreated sleep apnea.
Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis
The IGNITE study, which evaluated two dose strengths of rocatinlimab, met its co-primary endpoints and all key secondary endpoints, achieving statistical significance for both rocatinlimab dose strengths versus placebo.
Celebrating the Best in Patient Safety: Healthgrades Announces 2025 Top Hospitals for Patient Safety
This year's recipients include 442 hospitals from 40 states and represent the top 10% of hospitals in the nation for patient safety. Patient safety is a vital component of achieving the best possible health outcomes, ensuring that serious injuries and complications are minimized for patients during hospital stays.
U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®
The availability of the first omalizumab biosimilar will help increase access and potentially lower the healthcare cost for people with asthma and allergic diseases.
Make-A-Wish Receives $250,000 Grant from U.S. Bank Foundation to Help Support Life-Changing Wishes Nationwide "Together with the U.S. Bank Foundation, we look forward to granting wishes that can replace fear with hope and transform the lives of wish kids and their families," said Leslie Motter, president and CEO of Make-A-Wish America.
Health is Wealth: MyFitnessPal's Third Annual Nutrition IQ Survey Exposes Americans' Nutritional Blind Spots Amid Rising Food Prices While the new year traditionally inspires health-oriented resolutions, current economic pressures are adding a layer of complexity. Rising food prices further complicate efforts to prioritize nutrient-dense options in grocery carts, creating a substantial barrier for many.
Clayman Thyroid Center Launches Inaugural Hashimoto's Disease Awareness Day on March 12 Hashimoto's Disease Awareness Day, to be observed annually on the second Wednesday in March, is designed to bring much-needed attention to Hashimoto's thyroiditis, an autoimmune condition that affects millions yet remains misunderstood, underdiagnosed, and often dismissed.
The American Diabetes Association Announces the 2025 National Scientific and Health Care Achievement Award Winners "The diligent work of these passionate professionals is moving us closer to a world free of diabetes. Their contributions to research, prevention, and treatment are creating lasting change and improving the lives of people affected by diabetes," said Charles "Chuck" Henderson, the ADA's chief executive officer.
Lilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study "With these data, baricitinib is the most well-studied JAK inhibitor in severe alopecia areata, a chronic immune system disorder that can have an especially devastating social and emotional impact on adolescent patients and their families," said Anabela Cardoso, senior vice president, Lilly Immunology Medical Affairs.
Informa Connect Celebrates Successful HIMSS25, Announces Dates for HIMSS26 The conference featured 600+ educational sessions, 950+ exhibitors, numerous networking opportunities and a highly attended hosted buyer program that facilitated crucial conversations about the future of healthcare technology and delivery models.
Data Shows Quality of Life Improves for Spouses of Hip and Knee Replacement Patients When spouses were surveyed about their own quality of life compared to before their spouse's surgery, 70% said their quality of life was slightly or significantly better, 28% noted no change and 2% reported a slightly worse quality of life.
Sesame Place Philadelphia Is First Theme Park in North America to Launch Hidden Disabilities Sunflower Program Part of a global initiative designed to support people with non-visible disabilities and conditions, the program consists of a wearable Sunflower-branded tool that discreetly signals to Sesame Place Ambassadors that a guest may need extra help, understanding, or time due to a disability or condition that may not be immediately apparent.
Count Me In Launches New Patient-Partnered Research Project for Translocation Renal Cell Carcinoma tRCC is a unique type of kidney cancer caused by specific genetic changes called translocations, where parts of chromosomes s or rearrange. Due to its rarity, research on tRCC has historically been limited, leaving patients and families with few therapeutic options and many unanswered questions.
For more news like this, check out all of the latest health-related releases from PR Newswire.
Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most.
Helping Journalists Stay Up to Date on Industry News
These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists.
Once they're signed up, reporters, bloggers, and freelancers have access to the following free features:
Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more.
Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story.
Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles.
Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more.
About PR Newswire
PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.
For questions, contact the team at [email protected].
SOURCE PR Newswire
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
440k+
Newsrooms &
Influencers
9k+
Digital Media
Outlets
270k+
Journalists
Opted In
GET STARTED
